Choi, H., Lee, J., Oh, H., Kim, M., Kho, B. G., Park, C. K., . . . Kim, Y. (2021). Efficacy and dose of afatinib in patients with non‐small cell lung cancer after failure of prior gefitinib or erlotinib treatment. Thorac Cancer.
Citação norma ChicagoChoi, Hayoung, Jae‐Kyeong Lee, Hyung‐Joo Oh, Min‐Seok Kim, Bo Gun Kho, Cheol Kyu Park, In‐Jae Oh, and Young‐Chul Kim. "Efficacy and Dose of Afatinib in Patients With Non‐small Cell Lung Cancer After Failure of Prior Gefitinib or Erlotinib Treatment." Thorac Cancer 2021.
MLA CitationChoi, Hayoung, et al. "Efficacy and Dose of Afatinib in Patients With Non‐small Cell Lung Cancer After Failure of Prior Gefitinib or Erlotinib Treatment." Thorac Cancer 2021.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.